SCHEDULE: PrimeCap Management Discloses 9.22% Stake in Elanco

PrimeCap Management Co/CA/ has reported a beneficial ownership of 9.22% in Elanco Animal Health Incorporated as of March 31, 2026.

Summary

• PrimeCap Management Co/CA/ has filed a Schedule 13G, indicating a significant ownership stake in Elanco Animal Health Incorporated.
• The filing, dated March 31, 2026, shows that PrimeCap Management Co/CA/ beneficially owns 45,840,956 shares of Elanco's common stock.
• This represents 9.22% of the class of securities.
• PrimeCap Management Co/CA/ has sole voting power over 45,573,360 shares and sole dispositive power over 45,840,956 shares.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it indicates significant investment from a reputable institutional manager, but does not provide operational or financial performance updates.

Positives

• PrimeCap Management Co/CA/ holds a substantial 9.22% stake in Elanco Animal Health Incorporated, suggesting confidence from a significant institutional investor.
• The reporting entity has sole voting and dispositive power over the majority of its holdings, indicating clear control and intent.

Future Outlook

This filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that significant institutional filings like this Schedule 13G from established asset managers such as PrimeCap Management Co/CA/ often signal conviction in a company's long-term prospects within the animal health sector, a market characterized by steady growth driven by pet ownership trends and the need for livestock productivity.

Stakeholder Impact

• Shareholders may view the increased stake by PrimeCap Management Co/CA/ as a positive signal of institutional confidence in Elanco's future performance.
• The filing does not directly impact employees, customers, suppliers, or creditors, as it solely concerns ownership structure.

Key Dates

Recommendation

The filing indicates a significant ownership stake by PrimeCap Management Co/CA/, suggesting institutional confidence. However, without accompanying financial performance data or strategic updates, it is prudent to maintain a 'hold' position, awaiting further information to justify a stronger recommendation.

Keywords

Elanco Animal Health, Schedule 13G, PrimeCap Management, Institutional Ownership, Beneficial Ownership, Securities Filing, Animal Health